PCMI
Paradigm Capital Management Inc’s Ocular Therapeutix OCUL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-400,000
| Closed | -$3.42M | – | 133 |
|
|
2024
Q4 | $3.42M | Hold |
400,000
| – | – | 0.16% | 63 |
|
|
2024
Q3 | $3.48M | Buy |
400,000
+100,000
| +33% | +$870K | 0.15% | 65 |
|
|
2024
Q2 | $2.05M | Buy |
300,000
+160,000
| +114% | +$1.09M | 0.09% | 81 |
|
|
2024
Q1 | $1.27M | Sell |
140,000
-20,000
| -13% | -$182K | 0.06% | 94 |
|
|
2023
Q4 | $714K | Buy |
160,000
+80,000
| +100% | +$357K | 0.04% | 106 |
|
|
2023
Q3 | $251K | Buy |
80,000
+40,000
| +100% | +$126K | 0.01% | 131 |
|
|
2023
Q2 | $206K | Hold |
40,000
| – | – | 0.01% | 134 |
|
|
2023
Q1 | $211K | Hold |
40,000
| – | – | 0.01% | 133 |
|
|
2022
Q4 | $112K | Hold |
40,000
| – | – | 0.01% | 142 |
|
|
2022
Q3 | $166K | Hold |
40,000
| – | – | 0.01% | 140 |
|
|
2022
Q2 | $161K | Hold |
40,000
| – | – | 0.01% | 145 |
|
|
2022
Q1 | $198K | Buy |
+40,000
| New | +$198K | 0.01% | 150 |
|